February 25, 2026

Medical Oddities: For the Birds—and the Brain

Birds for brains, blackout laughs, anti-aging tea, thin air, muscle memory—and torn marriages, all with a clinical touch this week.

Conexiant

February 23, 2026

Hypertension: Biomarkers Clarify Heart Failure Risk

Cardiac biomarkers help stratify heart failure risk among patients with prediabetes and hypertension.

Conexiant

February 12, 2026

FDA Approves HRT Label Changes

The agency cited updated evidence in revising hormone therapy safety language.

Conexiant

February 12, 2026

Abortion and Breast Cancer: Any Link?

Analysis of more than 30,000 breast cancer cases finds no increased risk of breast cancer following induced abortion or miscarriage

Conexiant

February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

September 19, 2025

Vaccine Playbook Rewrite: Who’s In Charge?

HHS Secretary Robert F. Kennedy Jr.’s changes at the CDC are prompting states and medical societies to issue independent vaccine recommendations, challenging long-standing national immunization policy.

KFF Health News

January 30, 2026

Alzheimer Biomarkers Higher in Women

Researchers identify sex-specific differences in amyloid, tau, and brain structure during the seventh decade of life.

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.

Conexiant

December 10, 2024

Hormone Therapy Risks Vary: Tibolone Linked to Arterial Events

Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.

Conexiant